Current Status of the Diagnosis and Management of Osteoporosis
Open accessThe DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Abstract
Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and bone production. It is diagnosed through different methods such as bone densitometry and dual X-rays. The treatment of this pathology focuses on different aspects. On the one hand, pharmacological treatments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand, non-pharmacological treatments are associated with lifestyle habits that should be incorporated, such as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or smoking. This review seeks to provide an overview of the theoretical basis in relation to bone biology, the existing methods for diagnosis and the treatments of osteoporosis, including the development of new strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, it is thought that imbalances in these molecular and cellular processes alter bone homeostasis, driving the pathophysiology of osteoporosis [5,6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to bone densitometry, general blood and urine tests can provide important information about an individual’s overall health and any underlying conditions that may be contributing to osteoporosis.”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“This classification is widely accepted as a diagnostic criterion, with sensitivity and specificity close to 90% [6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149 · cited 1×
“The primary purpose of a pharmacological treatment is to reduce the risk of fractures and to improve the quality of life of people with osteoporosis [90].”
BackgroundEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Hernlund, E., Svedbom, A., Ivergård, M., Compston, J., Cooper, C., Stenmark, J., McCloskey, E. V., Jönsson, B., & Kanis, J. A. (2013) · Archives of Osteoporosis · doi:10.1007/s11657-013-0136-1 · Cited by 2,675 · cited 6×
“In 1993, the WHO defined osteoporosis as a systemic skeletal disease characterized by low bone mass, the deterioration of the microarchitecture of bone tissue, a consequent increase in bone fragility and a susceptibility to fractures [1].”
MethodInfluentialCompston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32112-3 · Cited by 2,449
An overview and management of osteoporosis
Sözen, T., Özışık, L., & Çalık Başaran, N. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2016.048 · Cited by 2,262 · cited 3×
“Individuals with uncomplicated osteoporosis may remain asymptomatic until a fracture occurs [5].”
BackgroundDiagnosis of osteoporosis and assessment of fracture risk
Kanis, J. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08761-5 · Cited by 2,260 · cited 1×
“5–2; and (v) severe osteoporosis value: the risk is similar to that of established osteoporosis [89].”
BackgroundStroke risk factors, genetics, and prevention
Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952 · cited 1×
“It is another clear cause of bone density loss, not only because of the drop in hormone levels but also because, histologically, there is a decrease in the average thickness of the bone wall, but bone resorption remains high with aging [34].”
BackgroundEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900 · cited 1×
“race, since Caucasians and Asians are at a greater risk than Blacks and Polynesians [32]; sex, since it has been found that the risk is greater in women than in men [33]; and age, since each decade increases the risk by 1.”
BackgroundHorwitz, E. M., Prockop, D. J., Fitzpatrick, L. A., Koo, W. W. K., Gordon, P. L., Neel, M., Sussman, M., Orchard, P., Marx, J. C., Pyeritz, R. E., et al. (1999) · Nature Medicine · doi:10.1038/6529 · Cited by 1,824 · cited 1×
“Decades ago, clinical studies were already conducted in children, using bone marrow MSCs (BM-MSCs) for the treatment of severe osteogenesis imperfecta [140].”
Background
Research works printed but not linked: 2
- 31. Quevedo L.I. Martínez B.M. Castillo N.M. Rivera F.N. [Vitamin D receptor gene polymorphisms and risk of hip fracture in Chilean elderly women] Rev. Med. Chile 2008 136 475 481 18769790
- 107. Società Italiana Dell’osteoporosi del Metabolismo Minerale e delle Malattie dello Scheletro Clinical Cases in Mineral and Bone Metabolism: The Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases CIC Edizioni Internazionali Rome, Italy 2004
Cited by
Items 101–200 of 473
Application of artificial intelligence in osteoporosis: a review
Fan, S.-T., Lu, M., Dong, J.-L., Li, Y.-L., Hao, L.-N., Dong, R.-C., & Hou, M.-D. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1718554 · Cited by 10
Yan, H., Wang, S., Cao, H., Zhong, H., & Sun, C. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-05014-1 · Cited by 7
“Key features include reduced bone density, micro-structural deterioration, culminating in heightened bone fragility and fracture susceptibility [1, 2].”
BackgroundUSP10-mediated deubiquitination of NR3C1 regulates bone homeostasis by controlling CST3 expression
Zhou, L., Mu, S., Zhang, Y., & Song, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116519 · Cited by 9
Assessment of osteoporosis and vertebral fractures with T1- and T2-weighted MRI scans
Din, R. U., Wang, L., Cheng, X., & Yang, H. (2025) · Archives of Osteoporosis · doi:10.1007/s11657-025-01509-4 · Cited by 10
“Dual-energy X-ray absorptiometry (DXA) is a simple imaging modality with minimal radiation exposure to measure areal BMD and is the current gold standard imaging method for diagnosis of osteoporosis [11].”
Isoimperatorin improves osteoporosis by increasing YBX1 expression to promote BGLAP m5C modification
Hu, G., Wen, J., Yang, H., & Zhang, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-94215-7 · Cited by 7
Molecular mechanisms and targeted therapy of progranulin in metabolic diseases
Wang, X., Liang, Y., Yang, F., Shi, Y., Shao, R., Jing, R., Yang, T., Chu, Q., An, D., Qi, Z., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1553794 · Cited by 9
“It plays a role in in fl ammation, cartilage repair, and the maintenance of bone homeostasis in in fl ammatory diseases, OA, and bone homeostasis imbalance (10, 107, 108).”
Zhang, C., Li, Q., Ye, Z., Wang, X., Zhao, H., Wang, Y., & Zheng, X. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04494-x · Cited by 7
“Compounding this issue is the absence of specific drugs in clinical practice for a definitive cure, with existing treatments only capable of delaying OP progression and mitigating fracture risks [4].”
BackgroundZhang, Y., Zhang, Y., Yan, Y., Kong, X., & Su, S. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1420885 · Cited by 9
Recent advances in exploring the properties and applications of hyaluronan
Zeng, Q., Ding, D., Loka, R. S., Wang, S., & Ling, P. (2024) · Journal of Dermatologic Science and Cosmetic Technology · doi:10.1016/j.jdsct.2024.100039 · Cited by 7
Bauer, J., Duero, J., & Lindsay, A. D. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00922-5 · Cited by 6
“As the population continues to age and life expectancy lengthens, the incidence of osteoporosis is expected to rise concurrently [3].”
Zhang, Y., & Jing, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1615596 · Cited by 6
“Bone loss is a natural consequence of aging, particularly beyond middle age (6).”
Moroni, G. L., Reggiani, F., & Ponticelli, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1738675 · Cited by 6
“Physical exercise helps prevent cancer (12), CVD (13), diabetes (14), and osteoporosis (15).”
Liu, F., Zhu, H., Ma, J., Miao, L., Chen, S., Yin, Z., & Wang, H. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04174-w · Cited by 6
“SD is the standard deviation of peak BMD of a young normal reference population [26].”
BackgroundInfluentialAssociation Between Combined Polymetallic Exposure and Osteoporosis
Qin, L., Liu, Q., Zhang, T., Tang, X., Mo, X., Liang, Y., Wang, X., Cao, J., Huang, C., Lu, Y., et al. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-04002-6 · Cited by 6
Park, J. S., Kim, D. Y., & Hong, H. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24554 · Cited by 6
Li, M., Gao, X., Zhang, Y., Wang, J., Dong, R., Li, P., & He, Y. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673291526240322081017 · Cited by 6
A decade of insight: bibliometric analysis of gut microbiota’s role in osteoporosis (2014–2024)
Luo, Z. Q., Huang, Y. J., Chen, Z. H., Chen, L., Zhou, B., Gong, X. H., Shen, Z., & Wang, T. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1409534 · Cited by 7
Ding, X., Yang, J., Wei, Y., Wang, M., Peng, Z., He, R. Q., Li, X., Zhao, D., Leng, X., & Dong, H. (2024) · Phytotherapy Research · doi:10.1002/ptr.8397 · Cited by 6
“It presents a significant global public health challenge, particularly as the population continues to age (Aibar-Almazán et al. 2022; Walker and Shane 2023).”
Yin, B., Yang, M., Wang, B., Zhang, Y., Li, N., Li, Q., Li, Y., Xian, C. J., Li, T., & Zhai, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1513863 · Cited by 6
Zhang, W., Tang, Y. W., Chen, L., Zhang, Z., Hu, X., Cheng, K., Zhou, J., & Tong, P. (2025) · Geriatric Orthopaedic Surgery & Rehabilitation · doi:10.1177/21514593251357525 · Cited by 7
He, Q., Xie, L., Peng, H., Xiao, X., & Yu, T. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02135-8 · Cited by 6
Liu, D., Hu, Z., Tang, Z., Pan, L., Yuan, W., Li, F., Chen, Q., Wen, M., & Zhao, C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21501 · Cited by 6
Advances in exosome modulation of ferroptosis for the treatment of orthopedic diseases
Cui, H., Wang, Y., Ma, J., Zhou, L., Li, G., Li, Y., Sun, Y., Shen, J., Ma, T., Wang, Q., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155312 · Cited by 6
Koifman, E., Krasnopolsky, M., Ghersin, I., & Waterman, M. (2024) · Nutrients · doi:10.3390/nu16172827 · Cited by 6
“Smoking is a well-known risk factor for reduced bone density in the general population, possibly affecting vitamin D and calcium levels [15].”
BackgroundHypothyroidism correlates with osteoporosis: potential involvement of lipid mediators
Leng, P., Qiu, Y., Zhou, M., Zhu, Y., Yin, N., Zhou, M., Wu, W.-L., & Liu, M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1453502 · Cited by 6
Association of Osteoporosis with Tooth Loss and Dental Radiomorphometric Indices
Damanaki, A., Habel, M. L., & Deschner, J. (2024) · Biomedicines · doi:10.3390/biomedicines12122886 · Cited by 8
Zou, J., Mi, S., Chen, J., Wusiman, M., Ye, J., Yang, S., Chen, S. X., Huang, Z., Huang, B., Fang, A., et al. (2025) · Nutrients · doi:10.3390/nu17010192 · Cited by 7
“Currently, BMD assessment through dual-energy X-rays is the primary method used to diagnose osteoporosis clinically [4].”
Cheng, Y., Yi, Y., Bo, S., Jun, M., & Ma, J. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1589200 · Cited by 7
Zheng, Z., Fan, Y., Zhang, J., Wang, J., & Li, Z. (2024) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-024-00921-3 · Cited by 5
“Osteoporosis, which leads to increased bone fragility and fracture sensitivity, is a systemic bone disease characterized by the microstructure degradation of bone tissue and the loss of bone mass (Aibar-Almazán et al. 2022).”
Yoo, Y.-S., Kim, M.-G., Park, H.-J., Chae, M.-Y., Choi, Y., Oh, C., Son, C., & Lee, D. W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1413515 · Cited by 5
Lyu, F. F., Ramoo, V., Chui, P. L., & Ng, C. G. (2024) · Orthopaedic Nursing · doi:10.1097/nor.0000000000001059 · Cited by 5
Melatonin antagonizes bone loss induced by mechanical unloading via IGF2BP1-dependent m6A regulation
Xu, L., Zhang, L., Sun, Q., Zhang, X., Zhang, J., Zhao, X., Hu, Z., Zhang, S., & Shi, F. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05588-x · Cited by 7
Guo, C., Li, Y., Yang, R., Xie, M.-Z., Chen, X., Che, Z., Wang, Z., Zhong, B., Luo, Y., & Leng, X.-M. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04793-2 · Cited by 5
Qiu, D., Yan, B., Xue, H., Xu, Z., Tan, G., & Liu, Y. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114457 · Cited by 6
Sukkho, T., Khanongnuch, C., Lumyong, S., Ruangsuriya, J., Apichai, S., Surh, Y., Pattananandecha, T., & Saenjum, C. (2025) · Antioxidants · doi:10.3390/antiox14030252 · Cited by 5
“Furthermore, the rate of bone resorption significantly rises after menopause due to estrogen insufficiency, leading to a porous bone structure and low bone density, which accounts for increased fragility and a higher risk of fractures [1].”
Liu, X., Yang, G., Li, Y., Xiao, W., Lu, B., & Wang, Y. (2025) · Bioengineering · doi:10.3390/bioengineering12050435 · Cited by 6
Zeng, Y., Hu, M., Zhang, Z., Chen, J., Luan, F., Wu, Z., & Zheng, C. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1566421 · Cited by 5
“This gender-based reversal in fracture risk may be attributed not only to biological factors, such as accelerated bone loss after menopause (24, 25), but also to behavioral and lifestyle influences.”
Wen, Y., Cheng, S., Gou, L., Zhou, W., Li, Y., Wang, R., Wu, J. Y., Dai, X., Gao, M., Wang, L., et al. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s536568 · Cited by 5
“Nevertheless, DEXA has notable limitations, 20–22 including high costs of equipment, exposure to radiation, restrictions in measuring bone density, and the risk of false-positive findings.”
Advances in bone organoids research and future perspectives
Liu, J., Li, J. Y., Chen, Y., Xu, F., Liu, W., Deng, 志. Z. 邓., Zhong, H., & Yang, H. (2025) · Biofabrication · doi:10.1088/1758-5090/adffb9 · Cited by 6
“Osteoporosis is referred to as the ‘silent disease’ of the 21st century, characterized by bone mass reduction, microstructural deterioration, increased fragility, and high fracture risk [108, 109].”
Liu, J., Shi, S., Huang, H., Wang, C., & Liu, Y. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s580230 · Cited by 5
Lin, F., Chen, J., Chen, M., Lin, S., & Dong, S. (2023) · Phytotherapy Research · doi:10.1002/ptr.7954 · Cited by 5
“Osteoporosis (OP) is a metabolic bone disorder characterized by bone mass decrease, microarchitecture degeneration, and an elevated risk of fractures (Aibar-Almazan et al., 2022; Anam & Insogna, 2021).”
BackgroundChen, Y., Miao, Y., & Zhang, Q. (2024) · Osteoporosis International · doi:10.1007/s00198-024-07126-0 · Cited by 6
Parvaneh, M., Jamaluddin, R., Ebrahimi, M. M., Karimi, G., & Sabran, M. R. (2024) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-024-01512-8 · Cited by 5
Wanionok, N. E., Colareda, G. A., & Fernandez, J. M. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112328 · Cited by 5
Liu, S., Zhang, M., Gong, H., Jia, S., Zhang, J., & Jia, Z. (2024) · Journal of Orthopaedic Research® · doi:10.1002/jor.25962 · Cited by 5
Gallaway, G., Surowiec, R. K., Allen, M. R., Wallace, J. M., Pyrak‐Nolte, L. J., Howarter, J. A., & Siegmund, T. H. (2024) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2024.112359 · Cited by 5
Ma, T., Guan, Y., Zhang, Y., Feng, J., Yang, Y., Chen, J., Guo, W., & Liao, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137426 · Cited by 5
Zhang, X., Huang, F., Liu, J., Zhou, Z., Yuan, S., & Jiang, H. (2025) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70019 · Cited by 5
“Osteoporosis, which is currently the most common metabolic bone disease, is becoming a public health concern worldwide, particularly because its incidence increases with age [24].”
Chen, L., Lu, L., Fan, C., Zhu, X., Pan, L., Tang, S., Wang, Y., Peng, Y., & Li, Y. (2025) · Biomedical Journal · doi:10.1016/j.bj.2025.100870 · Cited by 6
“Currently, the treatments for osteoporosis primarily include bisphosphonates, vitamin D, and denosumab [6].”
Health Benefits of Phytosterols in the Management of Several Non‐Communicable Disorders
Aboutaleb, A. S., Mahdy, E. S., Khamies, S. M., Hal, D. M., El‐Dessouki, A. M., El‐Shiekh, R. A., Hassan, M., Elshazly, A. M., Salman, A., Sayed, G. A., et al. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500983 · Cited by 6
“Current therapies for osteoporosis involve supplementation with calcium and vitamin D, bisphosphonates, and HRT [307].”
Lan, Y., Peng, Q., Shen, J., & Liu, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-78707-6 · Cited by 4
“OP is characterized by an imbalance between bone formation mediated by osteoblasts and bone resorption mediated by osteoclasts 62 .”
Liang, J., Xu, J., Cao, Y., Wei, Y.-L., Lin, G.-J., Jin, J., Li, C., & Lü, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-98089-7 · Cited by 5
“The identification of OP was based on these conditions: (1) presence of bone weakness and fractures without other metabolic bone conditions, along with a standard BMD (T-score); (2) confirmation of OP with a T-score of − 2.5 or lower, even if no current bone fractures are present 25 .”
InfluentialLara, I. P., Calzada‐Mendoza, C. C., Mera-Jiménez, E., López, E. R., Espinoza, J. L. A., Parra‐Barrera, A., & Gutiérrez-Iglesias, G. (2025) · Journal of Medicinal Food · doi:10.1089/jmf.2024.0256 · Cited by 4
“18 – 23 Several in vitro investigations in which bone differentiation is induced in MSCs 24 – 27 traditionally uses commercial osteogenic mediums that includes in their formula some agents such as dexametasone, ascorbic acid, and others that for humans represent elevated pharmacological…”
The role of taurine in bone metabolism
Chen, X., Yuan, Y., Zhou, X., Deng, H., Zhang, J., Duan, S., & Ni, G. (2025) · iScience · doi:10.1016/j.isci.2025.113257 · Cited by 5
Fan, A., Zhang, J., & Ye, Q. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1706068 · Cited by 4
“Against this background, MASLD has emerged as an additional and potentially modi fi able determinant of skeletal fragility (29).”
RNA-binding proteins in bone pathophysiology
Maroni, P., Pesce, N. A., & Lombardi, G. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1412268 · Cited by 4
Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause
Palacios, S., Rodríguez, S. P. G., Prieto, M. S., & Fasero, M. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2383639 · Cited by 7
Lu, J., Chen, J., Jiang, Y., Liu, Y., Yu, S., Shi, Z., Chen, P., Lin, H., & Li, P. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s505443 · Cited by 6
“5 This has led to a growing interest in herbal interventions as alternative approaches for osteoporosis management.”
Xiao, D., Zhang, D., Qu, Y., & Su, X. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70483 · Cited by 4
“The management of bone defects has emerged as a significant clinical challenge due to the impaired bone regenerative capacity observed in individuals with OP [62, 63].”
Classification of Osteoporosis in Knee X-ray using Transfer Learning and Random Forest
Hidar, W. A., Mubarak, A. S., David, L. R., Hyssian, A. J., Tawfik, H., & Ozsahin, D. U. (2024) · International Conference on Developments in eSystems Engineering (DeSE) · doi:10.1109/dese63988.2024.10912021 · Cited by 5
Li, Y., Yin, T., Yang, Q., Han, H., Wang, Z., & Yu, W. (2025) · Frontiers in Medical Technology · doi:10.3389/fmedt.2025.1575553 · Cited by 4
Dai, X., Liu, C., Bi, W., Zheng, G., Lv, K., & Xia, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-02808-z · Cited by 5
Chen, P., & Lin, J. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.103025 · Cited by 4
Yue, G., Dai, X., Shi, H., Shen, J., Guo, H., Liang, R., Dai, Z., Li, Y., Gao, S., Dong, G., et al. (2025) · Biomaterials Science · doi:10.1039/d5bm00537j · Cited by 5
Tovsultanov, A., Gereykhanov, H., Asludinova, D., Khisimikova, K., Gashimova, Z., Khalifaeva, D., Khizriev, M., Magomedova, Z., Magomedova, G., & Eremina, A. (2025) · Journal Of Biochemical Technology · doi:10.51847/vm5h8y9dhq · Cited by 4
Wang, Y., Wang, Z., Zhang, Q., Jin, W., Zheng, Y., & Hu, X. (2025) · European journal of medical research · doi:10.1186/s40001-025-03392-8 · Cited by 4
“Pharmacological treatment involves the utilization of anti-resorptive drugs and regenerative medicine; while non-pharmacological treatment is associated with healthy lifestyles [6].”
Luo, Z., Zhu, W., Jiang, C., He, W., & Zuo, H. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06742-x · Cited by 4
“And attention should be given to personal dietary habits, including consuming a balanced diet rich in calcium, low in salt, and with adequate protein [24].”
BackgroundPotential causal associations of PM2.5 and osteoporosis: a two-sample mendelian randomization study
Zhang, Y., Yu, J., Pei, H., Zhao, X., Wang, C., Wang, G., Shen, Z., Jiang, H., & He, B. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1263916 · Cited by 5
Poiană, I. R., Dobre, R., Pițuru, S., & Bucur, A. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14080843 · Cited by 4
“It is a preventable and treatable disease, yet only a small proportion of people with increased risk for fracture are indeed evaluated and treated [3,4].”
BackgroundWu, Y., Xu, Z., Dong, J., Zhang, W., Li, J., & Ji, H. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s471924 · Cited by 4
“17,18 OP is associated with older age and female gender, 19 and the prevalence of OP in women aged ≥50 years old is around 30%.”
BackgroundNajafi, A., Bagheri, A. B., Hadavi, D., Mobedi, A., Azarsina, S., & Chaghamirzayi, P. (2024) · European Journal of Translational Myology · doi:10.4081/ejtm.2024.12311 · Cited by 8
Exploiting Machine Learning for Osteoporosis Risk Prediction and Early Intervention
Jararweh, M., Daraghmeh, M., & Ali, M. Z. (2024) · International Conference on Multimedia Computing, Networking and Applications (MCNA) · doi:10.1109/mcna63144.2024.10703888 · Cited by 4
Greggi, C., Montanaro, M., Scioli, M. G., Puzzuoli, M., Grillo, S. G., Scimeca, M., Mauriello, A., Orlandi, A., Gasbarra, E., Iundusi, R., et al. (2024) · Biomolecules · doi:10.3390/biom14101289 · Cited by 5
Ran, J., Yang, X., Li, S., & Peng, W. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s508268 · Cited by 4
Heel bone mineral density and various oral diseases: a bidirectional Mendelian randomization
Zhou, Y.-S., Song, J., Zheng, Z.-J., Li, S., Liu, J.-G., & Peng, J. (2023) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-023-01443-w · Cited by 5
“Osteoporosis (OP) is characterized by the decrease of bone mass and the progressive degeneration of bone microstructure, which can lead to the gradual increase of bone fragility, and finally, make the whole body's bone tissue prone to fracture [1, 28].”
BackgroundLang, H., Li, H., Zhang, A., & Li, N. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114523002477 · Cited by 4
“Osteoporosis, the most prevalent bone disease worldwide, is characterised by reduced bone mineral density (BMD) and deterioration of microstructure, resulting in fragility fractures that significantly impair patients ’ quality of life and increase their risk of mortality and disability (1,2) .”
BackgroundBridging Bone Health: Osteoporosis Disparities in the Rio Grande Valley
Bialaszewski, R. P., Gaddis, J. M., Martin, B. C., Dentino, P., & Ronnau, J. (2023) · Cureus · doi:10.7759/cureus.51115 · Cited by 4
“These dietary patterns, potentially lacking in essential bone-healthy elements like calcium, vitamin D, and zinc, may contribute to an increased susceptibility to osteoporosis [1,21].”
BackgroundMethodResultInfluentialKnowledge Mapping of Macrophages in Osteoporosis: A Bibliometric Analysis (1999–2023)
Jia, H., Li, H., Rong, Y., Jiang, K., Liang, X., & Li, G. (2024) · Orthopaedic Surgery · doi:10.1111/os.14159 · Cited by 5
Jiang, F., Xie, X., Pang, X., & Li, Z. (2024) · Medicine · doi:10.1097/md.0000000000036881 · Cited by 3
Plant‐derived nanovesicles offer a promising avenue for anti‐aging interventions
Meng, Y., Sun, J. Y., Yu, T., & Piao, H. (2024) · Physiologia Plantarum · doi:10.1111/ppl.14283 · Cited by 3
Tang, M., Sun, L., Song, F., & Chen, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1472146 · Cited by 3
Serological Assessment of Toxoplasma Gondii Infection in Marriage Applicants and Blood Donors
Alaa, S. J., & Nuha, J. A. (2025) · Лабораторная диагностика Восточная Европа · doi:10.34883/pi.2025.14.1.016 · Cited by 14
Identification and verification of oxidative stress-related genes in the diagnosis of osteoporosis
Liu, Z., Yang, X., Wang, Z., Li, Q., Gu, H., Meng, Q., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-06118-2 · Cited by 3
“Currently, bone densitometry and dual X-rays are common diagnostic methods for OP 6 .”
Yang, Y., Chen, Z., Hu, Y., Zhou, F., Zhang, Z., Lv, Y., Ji, H., Guo, Y., Hou, G., & Tian, Y. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08977-2 · Cited by 3
Frost, K., Urbanowski, A. M., Neag, G., Lewis, J. W., Northall, E., Kemble, S., Powell, E., Croft, A. P., Iqbal, A. J., Rainger, G. E., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118489 · Cited by 3
Ge, Q., Zou, Y., Deng, H., Yang, Z., Ge, L., Huang, J., Cai, J., & Wang, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1632882 · Cited by 3
Modiz, C., Castoldi, N. M., Scheiner, S., Martínez‐Reina, J., Calvo‐Gallego, J. L., Sansalone, V., Martelli, S., & Pivonka, P. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1619276 · Cited by 3
Long, C., Li, X., Fan, Y., Hu, Y., He, W.-G., Hu, N., & He, F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333897 · Cited by 4
“The primary treat-ment medications consist of inhibitors of bone resorption, promoters of bone formation, and traditional Chinese medicine [31].”
Gu, H., Han, K., Li, J., Zhang, Z., Xing, L., Hu, Y., Xie, Y., & Yu, H. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01114-8 · Cited by 3
Mahanur, V. B., Khandale, N. B., Tekade, M. S., & Singh, S. K. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115287 · Cited by 4
Physical Activity and the Optimization of Bone Mineral Density in Adolescents: A Systematic Review
Antoranz, Y., Freire, M. R., & Tejero‐González, C. M. (2025) · Physiologia · doi:10.3390/physiologia5040051 · Cited by 3
“The World Health Organization (WHO) defines osteoporosis as a systemic skeletal disease characterized by the deterioration of the bone tissue microarchitecture [17–19].”
InfluentialNa, X., Yang, Y., Yang, H., Chen, Z., Qu, X., Zhang, J., Chen, M., Wang, D., Breuillé, D., Yu, K., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1612739 · Cited by 3
Xiao, J., & Ning, Z. (2025) · Nutrición Hospitalaria · doi:10.20960/nh.05893 · Cited by 3
Chen, Z., & Zhang, L. (2025) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2025.102078 · Cited by 6
Hadadi, I. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1768327 · Cited by 3
Liu, H., He, S., Yang, J., Lin, C., Tang, B., Hou, Y., Liping, Y., Fang, Q., Wang, X., Li, W., et al. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107321 · Cited by 3
Zeng, J. S., Qian, Y., Yang, J., Chen, X., Fu, C., Che, Z., Feng, Y., & Yin, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28229 · Cited by 4
“In patients with T2DM, smoking not only increases the risk of all-cause mortality also aggravates OP and glycemic control [175, 176].”
Lu, S., Zhu, Y., Lin, J., Li, Y., & Wu, L. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad5260 · Cited by 4
“Op is characterized by the reduction of bone mass and changes in bone microarchitecture, leading to bone fragility and increased risk of fractures [1].”
BackgroundHe, J., Zeng, W., Ye, X., Niu, X., Liu, J., & Chen, Z. (2024) · Current Drug Therapy · doi:10.2174/0115748855342971240816120237 · Cited by 3
Xu, L., Liu, X., Chen, J., Xu, L., Yang, A., & Li, Z. (2025) · ACS Omega · doi:10.1021/acsomega.4c11505 · Cited by 3
Metadata
- Authors
- Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E.
- Affiliations
- Department of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain
- Universidad de Granada (ES)
- Fundación Universitaria del Área Andina (CO)
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-08-21
- Volume
- 23
- Issue
- 16
- Pages
- 9465
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9408932
- OpenAlex
- W4293030541
- Cited by
- 412
- References
- 229
- Citations by year
- 2026: 79 · 2025: 156 · 2024: 128 · 2023: 43 · 2022: 6
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- 2014–2020 Operational Programme FEDER in Andalusia (FMM-AP17196-2019)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteoporosis, osteoporosis diagnosis, bone densitometry, dual-energy X-ray absorptiometry, anti-resorptive drugs, regenerative medicine, cell therapy, bioactive hydrogels, non-pharmacological treatment, physical activity, diet, smoking, alcohol consumption, bone resorption, bone biology, postmenopausal women, older adults
- MeSH terms
- Aged, Bone Resorption, Female, Humans, Osteoporosis, Smoking, Health Behavior, Exercise, Bone Density, Osteoporosis, Postmenopausal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.